EXELTIS, rethink health.

One Step Forward in Developing Health



Exeltis is a branded pharmaceutics firm of CHEMO, an integrated group of health sciences. It is the fruit of the natural improvement and constant expansion of the branded pharmaceutics firm of Chemo Group.

ABOUT

Exeltis is the result of the natural evolution and sustained growth of the CHEMO pharmaceutical business, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a global organization with the capacity to discover, develop, produce and market medicinal products and medical devices that can help to improve the quality of life of millions of people worldwide.


ABOUT

R&D



Working synergistically with the R&D department, the Business Development department of Exeltis Turkey has been shaping the firm’s future according to the needs of patient and doctor with the aim of improving the product portfolio.


R&D

HUMAN RESOURCES



Exeltis draws its strength from the devoted work of its employees, experienced and expert in their field. Our being in tandem with all our units in line with the rules of the sector and the company objectives has ensured us to make our products and services top quality and to increase our competitiveness.


HUMAN RESOURCES

Exeltis, produces power and R&D when it leads to excellence

Every Day Perfect Realızatıon Is An Expressıon

4000

+

Professional

The projects carried out in Exeltis R&D are made up of experienced patent attorneys, pharmacists, chemists, chemical engineers and bioengineers. ..

300

+

Product

With the potential of CHEMO Group, it develops patented and qualified products for the European, American and LATAM markets as well as the Turkish market.

TREATMENT AREAS



Exeltis has been performing studies on a lot of treatment fields, especially women’s health, in order to advance human health.

WOMEN'S HEALTH

RESPIRATORY

TOPICAL ACHE

News / Announcement

You can regularly keep on following us with our up to date news and notices.

WOMEN SPECIFIC

<